跳至主要内容
临床试验/ACTRN12623000884606
ACTRN12623000884606尚未招募1 期

Effects of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) administered by intramuscular injection on frequency oscillatory power bands in healthy adults

Swinburne University of Technology, Hawthorn0 个研究点目标入组 15 人开始时间: 2023年8月17日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 40 Years(—)
性别
All

入选标准

  • Physically and mentally healthy.
  • Good command of the English language.
  • Prior experience with a psychedelic without experiencing adverse events.
  • Normal baseline ECG (determined by study medic).
  • Informed consent.
  • No psychedelic use within 2 weeks prior to the experiment.
  • Email access.
  • No anaemia.
  • Normal healthy body mass index (i.e., between 18.5-24.9).
  • Not use caffeine or nicotine 2 hours before or 6 hours after the dose.

排除标准

  • Not physically and mentally healthy.
  • No command of the English language.
  • No prior experience with a psychedelic without experiencing adverse events.
  • Abnormal baseline ECG (determined by study medic).
  • No informed consent.
  • Psychedelic use within 2 weeks prior to the experiment.
  • No email access.
  • Abnormal body mass index (i.e., below 18,5 or above 24,9).
  • Not use caffeine or nicotine 2 hours before or 6 hours after the dose.

研究者

发起方
Swinburne University of Technology, Hawthorn

相似试验